Glass House Brands operates as a vertically integrated cannabis company in California, and its results often serve as a useful indicator for the state's wholesale biomass market. This particular quarter is notable as the first full reporting period after the mid-2026 deconsolidation of its retail operations, so the numbers now provide a clearer view of the wholesale and cultivation side. I am watching closely to see whether the record output can help counter softer wholesale prices and a heavier trim mix, and whether the per-pound cost gains are building toward sustainable profitability. Cash generation remains a key focus, given management's emphasis on reaching cash-flow positive operations.
For the third quarter ended September 30, 2026, Glass House Brands posted revenue of $56.8 million. That compares with $47.0 million in the second quarter of 2026 and $26.2 million in the third quarter of 2025. Biomass production hit a new company record of approximately 319,000 pounds, up from 246,000 pounds in the previous quarter. Production costs improved to roughly $110 per pound from $122 per pound on a sequential basis.
Gross profit reached $14.9 million, close to the $15.8 million from the second quarter, yet the gross margin contracted to 26% from 34%. The margin pressure stemmed from a lower average selling price of $150 per pound versus $211 previously, along with a trim-heavy sales mix. Operating cash flow was negative $0.4 million, while cash, restricted cash, and equivalents rose to $39.7 million from $22.1 million. Management kept its full-year 2026 production target at roughly one million pounds and its longer-term cost goal of $95 per pound.
Investor views on Glass House Brands reflect two main themes: solid gains in production scale and costs on one side, offset by softer pricing in the California wholesale market on the other. The record harvest and reduced cost per pound highlight the company's advantages at scale, but the decline in average selling price and narrower margin point to ongoing supply pressure. Management's move to suspend its at-the-market offering program and its focus on cash-flow positivity were viewed positively, though the margin impact kept overall sentiment measured. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Going forward, attention will center on whether Glass House Brands can translate its production volume into stronger margins. Management expects fourth-quarter production costs to remain roughly in line with the third quarter and continues to target about one million pounds of biomass for the full year. The long-term $95-per-pound cost objective stays in place, and progress there will likely shape future discussions.
Product mix will matter as well. A shift toward more flower and smalls, rather than lower-value trim, could support better pricing and help margins recover. On the cost front, the Greenhouse 2 expansion and facility upgrades, including automation and climate controls, should aid further efficiencies.
Broader California wholesale prices, along with any progress on interstate commerce or export options, will also influence results. Regulatory steps such as rescheduling or out-of-state sales could widen the market opportunity, though timing remains unclear. Cash-flow trends deserve close monitoring, as turning cash-flow positive would represent a meaningful milestone.
When analyzing names like this, I often turn to Tickeron’s AI Screener to quickly compare fundamentals, technical patterns, and sector momentum across peers. It helps surface relevant ideas and track shifts in the cannabis space without manual effort, which fits well into a routine review of earnings and outlook.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where GLAS advanced for three days, in 199 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for GLAS just turned positive on October 28, 2026. Looking at past instances where GLAS's MACD turned positive, the stock continued to rise in 26 of 36 cases over the following month. The odds of a continued upward trend are 72%.
GLAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GLAS as a result. In 72 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GLAS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for GLAS entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.699) is normal, around the industry mean (6.379). P/E Ratio (-2.737) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (3.880) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. GLAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PharmaceuticalsGeneric